Geron Corporation

GERN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Sep 2025 Jun 2025 Mar 2025 Sep 2024 Jun 2024 Mar 2024
Revenue $57.5M $51.8M $47.2M $49.0M $39.6M $28.3M $882.0K $304.0K
Cost of Revenue — — — — — — — —
Gross Profit — — — — — — — —
Gross Margin — — — — — — — —
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense $38.9M $35.4M $39.0M $38.6M $40.0M $35.9M $39.4M $27.1M
Operating Income $-12.5M $158.0K $-13.9M $-12.5M $-16.7M $-28.2M $-69.3M $-56.1M
Operating Margin -21.7% 0.3% -29.4% -25.4% -42.2% -99.8% -7,860.9% -18,465.1%
Interest Expense — — — — — $3.0M $3.3M $3.4M
Pretax Income — — — — — — — —
Income Tax Expense — — — — — — — —
Net Income $-16.7M $-3.6M $-18.4M $-16.4M $-19.8M $-26.4M $-67.4M $-55.4M
Net Margin -29.0% -7.0% -39.0% -33.4% -50.1% -93.5% -7,639.8% -18,220.4%
EPS (Basic) $-0.02 $-0.01 $-0.03 $-0.02 $-0.03 $-0.04 $-0.10 $-0.09
EPS (Diluted) $-0.02 $-0.01 $-0.03 $-0.02 $-0.03 $-0.04 $-0.10 $-0.09
Shares Outstanding (Basic) 670.7K 669.4K 667.1M 666.2M 665.9M 662.2M 653.9M 603.5M
Shares Outstanding (Diluted) 670.7K 669.4K 667.1M 666.2M 665.9M 662.2M 653.9M 603.5M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 8 Older →